Literature DB >> 11440399

Haemolytic anaemia and exercise intolerance due to phosphofructokinase deficiency in related springer spaniels.

E Skibild1, K Dahlgaard, Y Rajpurohit, B F Smith, U Giger.   

Abstract

Phosphofructokinase (PFK) deficiency is an autosomal recessive inherited disorder in dogs causing haemolytic crises and exertional myopathy. The clinical signs may be confused with those of recurrent immune-mediated haemolytic anaemia. The deficiency has been commonly observed in field trial (working) English springer spaniels (ESSPs), but also in the conformation line of ESSPs in the USA over the past two decades. This report documents the first family of ESSPs found with PFK deficiency in Europe. Two related adult ESSPs in Denmark had intermittent signs of pigmenturia after exercise (hunting) and had evidence of a regenerative haemolytic anaemia. Based upon DNA sequencing data, both dogs had the previously described nonsense point mutation in the muscle-type PFK gene (delta2228G-->A). Study of 17 related family members using a simple and accurate PFK-DNA test revealed one additional PFK-deficient dog (with minor exercise intolerance), nine carriers and seven normal (or 'clear') ESSPs. Recently, the authors have also identified PFK carriers and affected ESSPs in the UK. Screening for PFK deficiency is recommended for ESSPs with suspicious clinical signs and before using any for field trials or breeding in order to prevent the further spread of this hereditary disorder.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11440399     DOI: 10.1111/j.1748-5827.2001.tb02043.x

Source DB:  PubMed          Journal:  J Small Anim Pract        ISSN: 0022-4510            Impact factor:   1.522


  2 in total

1.  Hereditary phosphofructokinase deficiency in wachtelhunds.

Authors:  Anna Hillström; Harold Tvedten; André Rowe; Urs Giger
Journal:  J Am Anim Hosp Assoc       Date:  2011-02-10       Impact factor: 1.023

2.  Frequency of five disease-causing genetic mutations in a large mixed-breed dog population (2011-2012).

Authors:  Sharon Zierath; Angela M Hughes; Neale Fretwell; Mark Dibley; Kari J Ekenstedt
Journal:  PLoS One       Date:  2017-11-22       Impact factor: 3.240

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.